This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.



  • Daily Antibiotics Recommended to Prevent Resistant TB Strains
    A computer model of tuberculosis has shown that approved treatments prescribing antibiotic doses once or twice a week are more likely to lead to drug resistant strains than are daily antibiotic regimens. The finding, from a University of Michigan study, could help inform ...More
    November 23, 2015 Posted in News
  • Scripps Florida Team Discovers Compounds With Potential to Treat Persistent Tuberculosis
    Tuberculosis has been infecting humans for several millennia, making it one of the most horribly successful diseases in history. Today, it is still a major killer, responsible for some 1.5 million deaths each year. In a substantial number of cases--some 2 billion, in ...More
    November 18, 2015 Posted in News
  • Study Sheds Light on Why Parasite Makes TB Infections Worse
    Scientists have shown how a parasitic worm infection common in the developing world increases susceptibility to tuberculosis. The study demonstrated that treating the parasite reduces lung damage seen in mice that also are infected with tuberculosis, thereby eliminating the ...More
    November 16, 2015 Posted in News
  • Study Offers New Recommendations for TB Vaccine Testing in Humans
    When results from a landmark tuberculosis vaccine trial in Cape Town, South Africa were published in The Lancet in February 2013, the headlines were grim, despite hopes that the trial would point toward a successful way to thwart one of the globe’s biggest public ...More
    November 12, 2015 Posted in News
  • Study Reveals Structure of Tuberculosis Enzyme, Could Offer Drug Target
    A team of scientists, including several from the U.S. Department of Energy’s Argonne National Laboratory, have determined the structures of several important tuberculosis enzymes, which could lead to new drugs for the disease. ...More
    November 2, 2015 Posted in News
  • TB Ranks Alongside HIV as a Leading Cause of Death Worldwide, WHO Report Says
    The fight against tuberculosis is paying off, with this year’s death rate nearly half of what it was in 1990. Nevertheless, 1.5 million people died from TB in 2014. Most of these deaths could have been prevented, according to the World Health Organization ...More
    October 28, 2015 Posted in News
  • Stopping Tuberculosis Requires a New Strategy, Researchers Say
    Unless there is a major shift in the way the world fights tuberculosis--from a reliance on biomedical solutions to an approach that combines biomedical interventions with social actions--the epidemic and drug resistance will worsen, say researchers at Harvard T.H. Chan ...More
    October 26, 2015 Posted in News
  • Tulane Researchers Working on New Tuberculosis Vaccine
    Researchers at the Tulane National Primate Research Center (TNPRC) are leading efforts to find a new vaccine for tuberculosis, one of the world’s deadliest diseases. Tuberculosis, a contagious infection of the lungs, affected more than 9 million people in 2013, ...More
    October 14, 2015 Posted in News
  • TTUHSC El Paso to Research TB Vaccine
    A $375,000 grant from the Robert J. Kleberg Jr. and Helen C. Kleberg Foundation was awarded to Subramanian Dhandayuthapani, PhD, an associate professor in the Center of Emphasis in Infectious Diseases at the Texas Tech University Health Sciences Center (TTUHSC) El Paso Paul ...More
    September 23, 2015 Posted in News